Monoporous Microsphere as a Dynamically Movable Drug Carrier for Osteoporotic Bone Remodeling

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Osteoporotic bone defects require simultaneous treatment of osteoporosis and enhancement of bone regeneration.
• Conventional drug carriers often lead to suboptimal drug release and local accumulation, hindering effective treatment.

Purpose of the Study:

• To develop a novel monoporous microsphere (MPM) carrier for precise, in situ delivery of parathyroid hormone (PTH).
• To minimize topical drug accumulation and achieve systemic repair of osteoporotic bone defects.

Main Methods:

• Construction of specifically monoporous microspheres (MPMs) encapsulating dosage-sensitive, short half-time PTH.
• In vitro evaluation of drug release kinetics and carrier mobility.
• In vivo assessment of MPM-PTH efficacy in repairing cranial defects and treating systemic osteoporosis.

Main Results:

• MPMs demonstrated controlled, gradual release of PTH from their single pore, improving initial drug concentration.
• MPMs exhibited self-shifting behavior with animal movement, effectively reducing in vitro topical drug aggregation.
• In vivo studies confirmed that MPMs-PTH dual-acted to stimulate cranial defect regeneration and alleviate systemic osteoporosis.

Conclusions:

• A dynamically movable drug delivery system using monoporous microspheres was developed.
• This system enables precise in situ delivery, minimizes topical accumulation, and facilitates systematic repair of osteoporotic bone defects.